Manulife (Manufacturers Life Insurance)’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-35,766
Closed -$239K 3041
2023
Q3
$239K Hold
35,766
﹤0.01% 2489
2023
Q2
$324K Buy
35,766
+3,033
+9% +$26.8K ﹤0.01% 2304
2023
Q1
$238K Hold
32,733
﹤0.01% 2441
2022
Q4
$239K Buy
32,733
+3,261
+11% +$24.2K ﹤0.01% 2445
2022
Q3
$228K Sell
29,472
-677
-2% -$5.75K ﹤0.01% 2500
2022
Q2
$205K Buy
+30,149
New +$231K ﹤0.01% 2657

Other funds holding PNT

Manulife (Manufacturers Life Insurance)'s PNT Position: Q4 2023 in Review

Manulife (Manufacturers Life Insurance) sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 35,766 shares — an estimated $239K sold.

Manulife (Manufacturers Life Insurance) first reported a position in PNT in Q2 2022 and held it in 6 quarters. The position peaked at $324K in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • Manulife (Manufacturers Life Insurance) reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 35,766 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $239K.
  • Manulife (Manufacturers Life Insurance) first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2022 and held it in 6 quarters.
  • Manulife (Manufacturers Life Insurance)'s POINT Biopharma Global Inc. Common Stock position peaked at $324K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2023, filed 13 Feb 2024.